ERBB2 and breast carcinoma: Although HER2 FISH or chromogenic in situ hybridization is not routinely performed in Rwanda for IHC-equivocal cases, if it were, this would double the cost of the assay for the 7% of breast cancer cases that tested HER2 equivocal in our study.